RADA16 FOR AQUABLATION DAY CASE (RAD)

Go Back to All Clinical Trials

RADA16 FOR AQUABLATION DAY CASE (RAD)

Brief description of study

The purpose of the study is to assess if the use of PuraStat after the Aquablation surgery can reduce the chance of hematuria to allow for same day discharge.

Following the Aquablation procedure, the PuraStat will be applied to the inside of the prostate, through the surgeon’s cystoscope, to help stop the bleeding. On average, it will take 2-3 minutes to apply PuraStat.

Clinical Study Identifier: s25-00109

ClinicalTrials.gov Identifier: NCT06948331

Principal Investigator: Christopher E Kelly.

Other Investigator: Joel Hillelsohn.

Contact the research team to learn more about this study.

Your Email

Not a valid e-mail address

Please Provide Email Address

First Name

First name is mandatory

Last Name

Your Phone

Please provide phone number

Invalid phone number

Valid phone number

Comments

Send Confirmation of This To Me

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Clinical Research Studies